RecruitingNCT03418441
Central Nervous System Infections in Denmark
Studying Encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Aalborg University Hospital
- Principal Investigator
- Henrik Nielsen, ProfessorAalborg University Hospital
- Intervention
- Community-acquired CNS infections(other)
- Enrollment
- 1900 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2030
Study locations (8)
- Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
- Department of Infectious Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark
- Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
- Herlev-Gentofte Hospital, Copenhagen, Denmark
- Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital Hillerød, Hillerød, Denmark
- Department of Infectious Diseases, Hvidovre Hospital, Hvidovre, Denmark
- Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
- Department of Pulmonary and Infectious Diseases, Sjællands University Hospital Roskilde, Roskilde, Denmark
Collaborators
Danish Study Group of Infections of the Brain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03418441 on ClinicalTrials.govOther trials for Encephalitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07332234Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesSpitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
- ACTIVE NOT RECRUITINGNCT06820060Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel PlusQIAGEN Gaithersburg, Inc
- ACTIVE NOT RECRUITINGPHASE2NCT06899802A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccineBavarian Nordic
- RECRUITINGPHASE1, PHASE2NCT06680128A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsSK Bioscience Co., Ltd.
- RECRUITINGNCT06368648CoMind Early Feasibility StudyCoMind Technologies Limited
- ACTIVE NOT RECRUITINGPHASE4NCT06678373Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasLiaoning Chengda Biotechnology CO., LTD
- RECRUITINGPHASE2NCT06510426Early Interferon-beta Treatment for West-Nile Virus InfectionTel-Aviv Sourasky Medical Center
- RECRUITINGNCT07191223Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in FranceUniversity Hospital, Strasbourg, France